Davenport, A. J., Neagoe, I., Bräuer, N., Koch, M., Rotgeri, A., Nagel, J., . . . Fischer, O. M. (2021). Eliapixant is a selective P2X3 receptor antagonist for the treatment of disorders associated with hypersensitive nerve fibers. Nature Portfolio.
Chicago Style (17th ed.) CitationDavenport, Adam J., et al. Eliapixant Is a Selective P2X3 Receptor Antagonist for the Treatment Of disorders associated With hypersensitive nerve Fibers. Nature Portfolio, 2021.
MLA (8th ed.) CitationDavenport, Adam J., et al. Eliapixant Is a Selective P2X3 Receptor Antagonist for the Treatment Of disorders associated With hypersensitive nerve Fibers. Nature Portfolio, 2021.
Warning: These citations may not always be 100% accurate.